Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 509 Cyclophosphamide 360 Carboplatin 352 Radiotherapy 350 Capecitabine 329 Paclitaxel 325 Oxaliplatin 324 Gemcitabine 319 Docetaxel 311 Fluorouracil 283 Drug Therapy 243 apatinib 242 Bevacizumab 229 camrelizumab 214 Etoposide 200 Irinotecan 176 Doxorubicin 175 Leucovorin 161 Dexamethasone 160 sintilimab 142 pembrolizumab 138 anlotinib 136 Pemetrexed 136 Cytarabine 136 toripalimab 129 Neoadjuvant Therapy 122 S 1 (combination) 120 Vincristine 119 Rituximab 117 Radiosurgery 117

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × OKN 007 × Clear all

NCT01672463 2023-03-29

OKN-007

Oblato, Inc.

Phase 1 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡